2020
DOI: 10.3855/jidc.12145
|View full text |Cite
|
Sign up to set email alerts
|

KPC-2 producing Pseudomonas putida as an unexpected pathogen of catheter-associated bloodstream infection

Abstract: Infections due to multidrug resistant Gram-negative pathogens are of great concern worldwide, as they are frequently associated with high mortality and morbidity rates. The occurrence of Pseudomonas spp. producing Klebsiella pneumoniae carbapenemases (KPCs) imposes a great challenge through treatment course of bloodstream infections (BSIs). Pseudomonas putida has been recognized as an emerging pathogen of healthcare associated infections (HAIs). Therefore, we aimed to report a case of a non-fatal case of perip… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 10 publications
0
5
0
Order By: Relevance
“…This illustrates the demand for clear etiological discrimination in patients with fever. P. putida is widely found on hospital surfaces and moist environments and, as an opportunistic pathogen, can cause bloodstream infections [ 26 , 27 ]. Therefore, bloodstream infection surveillance is essential to characterize the public health threat [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…This illustrates the demand for clear etiological discrimination in patients with fever. P. putida is widely found on hospital surfaces and moist environments and, as an opportunistic pathogen, can cause bloodstream infections [ 26 , 27 ]. Therefore, bloodstream infection surveillance is essential to characterize the public health threat [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…Infections by other Pseudomonas species with an environmental origin and biotechnological potential, as Pseudomonas putida [ 112 , 113 , 114 , 115 ], have also been reported, although their prevalence is much lower. Besides intrinsic resistance determinants [ 116 , 117 ], the acquisition of carbapenemases, as KPC-2 [ 113 ], constitutes an additional risk for the efficient treatment of infections by these pathogens.…”
Section: Pseudomonas Aeruginosamentioning
confidence: 99%
“…Although, Pseudomonas aeruginosa is one of the principal agent responsible for hospital acquired infection [ 109 , 110 ], the other species of the genus (hereinafter called Pseudomonas sp. non aeruginosa ) exhibit limited pathogenicity to humans [ 111 ]. Pseudomonas AMR is mainly studied for P. aeruginosa , where acquired resistance to carbapenems could occur i) by mutation onto genes conducting to overexpression of efflux system or to overexpression of the cephalosporinase AmpC or to modification of porin protein D2 and ii) by HGT [ 110 ].…”
Section: The Bacterial Shuttle Concept: When Hydric Autochtonous Bmentioning
confidence: 99%
“…Resistance by carbapenemase production in Pseudomonas non aeruginosa is less described in clinical reports. However, the carriage of CEG like bla KPC-2 and bla VIM-2 (carried on an class 1 integron) respectively in a clinical isolates of Pseudomonas putida and Pseudomonas fulva has been noticed [ 111 , 112 ].…”
Section: The Bacterial Shuttle Concept: When Hydric Autochtonous Bmentioning
confidence: 99%